On January 24, 2023, David S. Cunningham notified ImmuCell Corporation of his intention to retire from the Board of Directors effective immediately following the company's 2023 Annual Meeting to be held on June 15, 2023. Mr. Cunningham's decision to retire from the Board does not arise from any disagreement with the company on any matter relating to the Company's operations, policies, practices or otherwise.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | -3.12% | +3.54% | +3.54% |
09/04 | Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024 | CI |
02/04 | ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing | MT |
1st Jan change | Capi. | |
---|---|---|
+3.54% | 4.26Cr | |
+26.37% | 4.5TCr | |
-1.01% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.34% | 2.61TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.28TCr | |
+26.99% | 1.21TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- ICCC Stock
- News ImmuCell Corporation
- David S. Cunningham Intends to Retire from the Board of Directors of David S. Cunningham